Medicine and Dentistry
Human Immunodeficiency Virus
100%
Circumcision
62%
Prevalence
42%
Infection
38%
COVID-19
35%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Platelet
28%
Wart Virus
25%
Blood Transfusion Reaction
25%
Erythrocyte
22%
Herpes Simplex Virus 2
20%
Disease
19%
Thrombocyte Transfusion
18%
Erythrocyte Transfusion
17%
Transplantation
17%
Blood Transfusion
16%
Health Care Cost
14%
Adolescent
13%
Apheresis
12%
Antiretroviral Therapy
12%
Convalescence
11%
Systematic Review
10%
Pediatrics
10%
Blood Product
9%
Blood Donor
8%
Transfusion Medicine
8%
Randomized Controlled Trial
8%
Cytomegalovirus
8%
Papillomavirus Infection
8%
Genital Ulcer
8%
Adverse Event
8%
Cohort Effect
8%
Plasma Exchange
8%
Bacterium Contamination
8%
Outpatient
7%
Antibody Response
7%
Emergency Department
7%
Bacterium Culture
7%
Sickle-Cell Disease
7%
Pathogen
6%
Human Immunodeficiency Virus Infection
6%
Blood Component
6%
Human Immunodeficiency Virus Prevention
6%
Kidney Graft
6%
Neutralizing Antibody
6%
Receptor Binding
5%
Symptom
5%
Viremia
5%
Venous Thromboembolism
5%
Babesiosis
5%
Keyphrases
United States
48%
Uganda
47%
COVID-19
44%
Confidence Interval
41%
Convalescent Plasma
36%
Rakai
35%
Transfusion
25%
Male Circumcision
22%
Hospitalization
21%
AIDS/HIV
20%
Herpes Simplex Virus 2 (HSV-2)
19%
High-risk Human Papillomavirus (HR-HPV)
18%
Voluntary Medical Male Circumcision
16%
Antiretroviral Therapy
16%
Platelet Transfusion
15%
Solid Organ Transplant Recipients
14%
COVID-19 Convalescent Plasma
14%
HIV-positive
14%
National Health Interview Survey
12%
NHANES
12%
Therapeutic Plasma Exchange
12%
Randomized Trial
12%
People Living with HIV (PLHIV)
12%
Antibody Response
11%
HIV Organ Policy Equity Act
11%
Red Blood Cell Transfusion
10%
Deceased Donor
10%
HIV+
10%
Foreskin
10%
HIV Infection
9%
Population-based Study
9%
Allergic Transfusion Reaction
9%
Prevalence Ratio
8%
Cytomegalovirus
8%
HIV-negative
8%
HIV Patients
8%
Organ Procurement Organization
8%
Vaccination
8%
HIV Incidence
8%
Platelets
8%
Incidence Rate
7%
Transplant Recipients
7%
Transplantation
7%
Antibody Level
7%
Risk Ratio
7%
Herpes Simplex Virus Type 2 Infection
7%
Viral Load
7%
Human Immunodeficiency Virus Type 1 (HIV-1)
7%
Adverse Events
6%
Epidemiology
6%
Immunology and Microbiology
Human Immunodeficiency Virus
78%
Severe Acute Respiratory Syndrome Coronavirus 2
52%
Blood Plasma
49%
COVID-19
37%
Transplant Procedure
27%
Prevalence
25%
Wart Virus
24%
Monospecific Antibody
21%
Vaccine Efficacy
19%
Herpes Simplex Virus 2
18%
Human Immunodeficiency Virus 1
18%
Neutralization
16%
Viral Load
15%
Antibody Response
15%
Titer
14%
Spike
14%
Vaccination Policy
14%
Transfusion Reactions
11%
Antibody Titer
11%
Neutralizing Antibody
10%
Cytotoxic T-Cell
9%
Cytokine
9%
Microbiome
8%
T-Helper Cell
8%
Cytomegalovirus
8%
Omicron Coronavirus Variant
7%
T Cell
7%
Hemocyte
7%
Kidney Transplantation
7%
Macrophage
6%
Arm
6%
Human Immunodeficiency Virus Infection
6%
Dendritic Cell
6%
Platelet
6%
Seroprevalence
6%
Antigen Presentation
6%
Epitope
6%
Mycobacterium Tuberculosis
5%
Receptor Binding
5%
Viremia
5%
Heat Shock
5%
Major Histocompatibility Antigen
5%
Superinfection
5%
ELISA
5%
